Anja Jentzsch
Research Subjects
Research Interests
Anja Jentzsch has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Bosse Andersson
AstraZeneca, Lund, Sweden
1 shared publication - Chimezie Ogbuji
17Case Western Reserve University School of Medicine, Cleveland, OH, USA
1 shared publication - Christine K. Denney
Eli Lilly and Company
1 shared publication - Christopher Domarew
Albany Medical Center, Albany, NY, USA
1 shared publication - Colin Batchelor
Royal Society of Chemistry, Thomas Graham House, Cambridge, CB4 0WF, UK
1 shared publication - Deborah L. McGuinness
Rensselaer Polytechnic Institute
1 shared publication
Latest Publications
- Open Access
- 17 May 2011
- Published by Springer Nature in Journal of Biomedical Semantics
- Vol. 2 (S2) , S1
The Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside
Background: Translational medicine requires the integration of knowledge using heterogeneous data from health care to the life sciences. Here, we describe a collaborative effort to produce a prototype Translational Medicine Knowledge Base (TMKB) capable of answering questions relating to clinical practice and pharmaceutical drug discovery. Results: We developed the Translational Medicine Ontology (TMO) as a unifying ontology to integrate chemical, genomic and proteomic data with disease, treatment, and electronic health records. We demonstrate the use of Semantic Web technologies in the integration of patient and biomedical data, and reveal how such a knowledge base can aid physicians in providing tailored patient care and facilitate the recruitment of patients into active clinical trials. Thus, patients, physicians and researchers may explore the knowledge base to better understand therapeutic options, efficacy, and mechanisms of action. Conclusions: This work takes an important step in using Semantic Web technologies to facilitate integration of relevant, distributed, external sources and progress towards a computational platform to support personalized medicine. Availability: TMO can be downloaded from http://code.google.com/p/translationalmedicineontology and TMKB can be accessed at http://tm.semanticscience.org/sparql.
- 17 May 2011
- Published by Springer Nature in Journal of Biomedical Semantics
- Vol. 2 (S2) , S1
Open AccessThe Translational Medicine Ontology and Knowledge Base: driving personalized medicine by bridging the gap between bench and bedside
Background: Translational medicine requires the integration of knowledge using heterogeneous data from health care to the life sciences. Here, we describe a collaborative effort to produce a prototype Translational Medicine Knowledge Base (TMKB) capable of answering questions relating to clinical practice and pharmaceutical drug discovery. Results: We developed the Translational Medicine Ontology (TMO) as a unifying ontology to integrate chemical, genomic and proteomic data with disease, treatment, and electronic health records. We demonstrate the use of Semantic Web technologies in the integration of patient and biomedical data, and reveal how such a knowledge base can aid physicians in providing tailored patient care and facilitate the recruitment of patients into active clinical trials. Thus, patients, physicians and researchers may explore the knowledge base to better understand therapeutic options, efficacy, and mechanisms of action. Conclusions: This work takes an important step in using Semantic Web technologies to facilitate integration of relevant, distributed, external sources and progress towards a computational platform to support personalized medicine. Availability: TMO can be downloaded from http://code.google.com/p/translationalmedicineontology and TMKB can be accessed at http://tm.semanticscience.org/sparql.